Inadequate management of cerebrovascular risk factors in participants of a public stroke prevention program in Austria.
The aim of our investigation was to identify frequencies and treatment quality of stroke risk factors in participants of a stroke prevention program in the province of Salzburg (Austria). A total of 9356 participants free of previous stroke were classified in three risk categories for suffering from ischemic stroke within the next 10 years and analyzed referring to history, therapy, and treatment quality of cerebrovascular risk factors. A total of 6519 (69.7%) participants were classified to be at low (<10%), 2232 (23.9%) at intermediate (10-20%) and 605 (6.5%) at high risk (>20%). Elevated blood pressure with the need for follow-up investigations was found in 5193 persons (55.5%); of 3713 (39.7%) persons with a history of hypertension, 3204 (86.3%) are under medical treatment, which is sufficient only in 765 patients (23.9%). Similar results were present for other well documented modifiable risk factors. In the investigated population there is high presence of stroke risk factors with inadequate treatment in most cases.
Iglseder
B
B
Department of Neurology, Christian Doppler Clinic, Paracelsus Private Medical School, Salzburg, Ignaz-Harrer-Strasse, Salzburg, Austria. b.iglseder@lks.at
Moroder
T
T
Staffen
W
W
Ladurner
G
G
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D001317:Austria / Q000453:epidemiology; D001794:Blood Pressure / Q000502:physiology; D003374:Coumarins / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D011446:Prospective Studies; D012307:Risk Factors; D020156:Salicylic Acid / Q000627:therapeutic use; D020521:Stroke / Q000145:classification / Q000453:epidemiology* / Q000517:prevention & control*
D000925:Anticoagulants; D003374:Coumarins; D020156:Salicylic Acid